Cargando…

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility

Objectives: The aim of this study was to characterize multiple sclerosis (MS) patients exposed to dimethyl fumarate (DMF) and to evaluate the predictors of therapeutic response. In addition, the study offers a picture of how DMF use has changed over the past few years in naive or switcher patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorefice, Lorena, Casaglia, Elisa, Fronza, Marzia, Frau, Jessica, Fenu, Giuseppe, Pilotto, Silvy, Coghe, Giancarlo, Barracciu, Maria A., Cocco, Eleonora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440841/ https://www.ncbi.nlm.nih.gov/pubmed/34539545 http://dx.doi.org/10.3389/fneur.2021.679355

Ejemplares similares

Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
por: Lorefice, Lorena, et al.
Publicado: (2023)

Brain Volume and Perception of Cognitive Impairment in People With Multiple Sclerosis and Their Caregivers
por: Fenu, Giuseppe, et al.
Publicado: (2021)

Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study
por: Lorefice, Lorena, et al.
Publicado: (2021)

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
por: Frau, Jessica, et al.
Publicado: (2018)

Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the World
por: Frau, Jessica, et al.
Publicado: (2021)

The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases
por: Frau, Jessica, et al.
Publicado: (2023)

A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls
por: Frau, Jessica, et al.
Publicado: (2018)

An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis
por: Fronza, Marzia, et al.
Publicado: (2021)

Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis
por: Coghe, Giancarlo, et al.
Publicado: (2019)

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers
por: Fenu, G., et al.
Publicado: (2018)

Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers
por: Pau, Massimiliano, et al.
Publicado: (2020)

Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod
por: Murgia, Federica, et al.
Publicado: (2023)

What do multiple sclerosis patients and their caregivers perceive as unmet needs?
por: Lorefice, Lorena, et al.
Publicado: (2013)

Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study
por: Pau, Massimiliano, et al.
Publicado: (2022)

Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population
por: Cocco, Eleonora, et al.
Publicado: (2013)

(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015)

Dimethyl Fumarate Ameliorates Paclitaxel-Induced Neuropathic Pain in Rats
por: Singh, Jagjit, et al.
Publicado: (2022)

Dimethyl fumarate transfer into human milk
por: Ciplea, Andrea I., et al.
Publicado: (2020)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
por: Kourakis, Stephanie, et al.
Publicado: (2020)

Gait and Functional Mobility in Multiple Sclerosis: Immediate Effects of Transcranial Direct Current Stimulation (tDCS) Paired With Aerobic Exercise
por: Pilloni, Giuseppina, et al.
Publicado: (2020)

Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors?
por: Frau, J., et al.
Publicado: (2016)

Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives
por: Lorefice, Lorena, et al.
Publicado: (2023)

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
por: Lorefice, Lorena, et al.
Publicado: (2023)

Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease
por: Warabi, Yoko, et al.
Publicado: (2019)

Neuroprotective Properties of Dimethyl Fumarate Measured by Optical Coherence Tomography in Non-inflammatory Animal Models
por: Dietrich, Michael, et al.
Publicado: (2021)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

Effects of Dimethyl Fumarate on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: Pooled Analysis Phase 3 DEFINE and CONFIRM Studies
por: Nakamura, Kunio, et al.
Publicado: (2022)

Case Report: Baló's Concentric Sclerosis-Like Lesion in a Patient With Relapsing-Remitting Multiple Sclerosis Treated With Dimethyl Fumarate
por: Kania, Karolina, et al.
Publicado: (2022)

Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis
por: Murgia, Federica, et al.
Publicado: (2020)

Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study
por: Idda, Maria Laura, et al.
Publicado: (2022)

Dimethyl fumarate for ischemic stroke
por: Kunze, Reiner
Publicado: (2017)

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
por: Kowalec, Kaarina, et al.
Publicado: (2017)

Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
por: Ferri, Caterina, et al.
Publicado: (2023)

Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
por: Yao, Yang, et al.
Publicado: (2016)

What gait features influence the amount and intensity of physical activity in people with multiple sclerosis?
por: Pau, Massimiliano, et al.
Publicado: (2021)

Washington R. Handy
Publicado: (1858)

Handy Method for Hypodermy
Publicado: (1873)

Effects of dimethyl fumarate on neuroprotection and immunomodulation
por: Albrecht, Philipp, et al.
Publicado: (2012)

Dimethyl fumarate mitigates optic neuritis
por: Zyla, Katarzyna, et al.
Publicado: (2019)

Drug-Repurposing Strategy for Dimethyl Fumarate
por: Giunta, Salvatore, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_15e3onfolb49cotl4ljgcefd1g